Filing Details
- Accession Number:
- 0001140361-17-045018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 12:56:27
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-05 12:56:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501989 | Cytomx Therapeutics Inc. | CTMX | Pharmaceutical Preparations (2834) | 273521219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706863 | Debanjan Ray | C/O Cytomx Therapeutics, Inc. 151 Oyster Point Blvd., Suite 400 South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-30 | 163 | $12.15 | 12,289 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2017-12-01 | 2,500 | $20.58 | 9,789 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- 163 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
Billionaire Hedge Funds
